White wasn't targeted in Sunday's 18-16 win over the Colts. QB Sam Darnold threw the ball 36 times in this game, but White couldn't get into the rotation while playing just nine offensive snaps. The ...

Trautman went without a target while playing 42 of the Broncos' 68 snaps on offense in Sunday's 34-26 win over the Packers. Trautman's 62 percent snap share led the way among Broncos tight ends, but ...

Huawei has returned to Taiwan's tablet market with a clear point of differentiation: eye protection. Unveiled on December 17, 2025, the MatePad 11.5 (2025) targets growing tablet demand by shifting ...

The U.S. is conducting airstrikes against ISIS targets in Syria in retaliation for the attack that killed two American soldiers and a U.S. interpreter on Saturday, officials said. Multiple sources ...

American forces struck dozens of suspected ISIS sites, making good on President Trump’s vow to avenge two American soldiers and a civilian U.S. interpreter killed by the group last week. By Eric ...

The strikes are in response to the killings of three Americans on Saturday. The U.S. military launched retaliatory strikes on Friday against dozens of ISIS targets in Syria, according to a statement ...

The U.S. military has launched strikes against Islamic State group infrastructure and weapons sites in Syria, officials said Friday, following an attack on U.S. and partner forces in Syria last week ...

The US struck multiple targets in Syria on Friday that the US military tied to ISIS as retaliation for the recent attack that killed two American service members there, according to two US officials. ...

While next year's midterms will determine whether Republicans can keep control of Congress after winning big in 2024, there are also a slate of gubernatorial elections, several that are toss-ups, ...

Strikes hit more than 70 ISIS targets Retaliatory strikes follow attack on US troops Trump says Syrian president backs US military action against ISIS Dec 19 (Reuters) - The U.S. military launched ...

Abbvie (ABBV) announced an update on their ongoing clinical study. Study Overview AbbVie is running a phase 3 trial called “A Multicenter, Double-masked, Randomized Study to Compare the Efficacy and ...